Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease)

Neurology

Volumn 46, Issue 3, 1996, Pages 619-627

  Halperin, John J ^a   Logigian, Eric L ^b   Finkel, Michael F ^c   Pearl, Richard A ^d  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Midelfort Clinic Ltd   (United States)

^d North Shore University Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; BORRELIA BURGDORFERI; CLINICAL FEATURE; DEMENTIA; HUMAN; LYME DISEASE; MULTIPLE SCLEROSIS; NEUROLOGICAL COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0029876164     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.3.619     Document Type: Review

References (66)

1. Hanrahan JP, Benach JL, Coleman JL, et al. Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis 1984;150:489-496.
2. Luger SW, Krauss E. Serologic tests for Lyme disease. Arch Intern Med 1990;150:761-768.
3. Schwartz BS, Goldstein MD, Ribeiro JM, Schulze TL, Shahied SI. Antibody testing in Lyme disease. A comparison of results in four laboratories [see comments]. JAMA 1989;262:3431-3434.
4. Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 1977; 86:685-698.
5. Afzelius A. Erythema chronicum migrans. Acta Derm Venereol Suppl (Stockh) 1921;2:120-125.
6. Scrimenti RJ. Erythema chronicum migrans. Arch Dermatol 1970;102:104-105.
7. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983;308:740-742.
8. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:733-740.
9. Garin, Bujadoux. Paralysie par les tiques. J Med Lyon 1922; 71:765-767.
10. Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine 1979; 58:281-294.
11. Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med 1983;99:767-772.
12. Wilske B, Barbour AG, Bergstrom S, et al. Antigenic variation and strain heterogeneity in Borrelia spp. Res Microbiol 1992; 143:583-596.
13. Asbrink E, Hederstedt B, Hovmark A. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 1984;64:506-512.
14. Centers for Disease Control. Case definitions for public health surveillance. MMWR 1990;39:19-21.
15. Asbrink E, Hovmark A. Aspects of tick-borne Borrelia burgdorferi infection from a dermatologic point of view. Semin Dermatol 1990;9:227-291.
16. Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A. Longitudinal assessment of the clinical and epidemiologic features of Lyme disease in a defined population. J Infect Dis 1986;154:295-300.
17. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988;319:1441-1446.
18. Dressler F, Yoshinari NH, Steere AC. The T-cell proliferative assay in the diagnosis of Lyme disease [see comments]. Ann Intern Med 1991;115:533-539.
19. Simpson WJ, Burgdorfer W, Schrumpf ME, Karstens RH, Schwan TG. Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals. J Clin Microbiol 1991;29:236-243.
20. Karlsson M, Hovind HK, Svenungsson B, Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 1990;28:473-479.
21. Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B. Diagnosis of spirochetal meningitis by enzyme linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol 1985;21:819-825.
22. Wilske B, Schierz G, Preac-Mursic V, et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis. J Infect Dis 1986;153:304-314.
23. Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology 1989;39: 753-759.
24. Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990;161:1203-1209.
25. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi - specific immunoglobulins G, A, and M. Ann Neurol 1991;30:197-205.
26. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 1991;41: 1571-1582.
27. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323:1438-1444.
28. Keller TJ, Halperin JJ, Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 1992;42:32.
29. Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992;267:1364-1367.
30. Berry CD, Hooton TM, Collier AC, Lukehart SA. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987; 316:1587-1589.
31. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987;316:1569-1572.
32. Hansen K, Lebech A-M. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. Brain 1992;115:399-423.
33. Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und "rheumatismus." Arch Psychiatr Nervenkr 1941;113:284-376.
34. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease. Neurology 1985;35:47-53.
35. Ackermann R, Gollmer E, Rehse KB. Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system. Dtsch Med Wochenschr 1985;110:1039-1042.
36. Ackermann R, Rehse KB, Gollmer E, Schmidt R. Chronic neurologic manifestations of erythema migrans borreliosis. Ann N Y Acad Sci 1988;539:16-23.
37. Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis - peripheral nervous system manifestations. Brain 1990;113:1207-1221.
38. Meier C, Grahmann F, Engelhardt A, Dumas M. Peripheral nerve disorders in Lyme borreliosis. Acta Neuropathol (Berl) 1989;79:271-278.
39. Camponovo F, Meier C. Neuropathy of vasculitic origin in a case of Garin-Bujadoux-Bannwarth syndrome with positive Borrelia antibody response. J Neurol 1986;233:69-72.
40. Vallat JM, Hugon J, Lubeau M, Leboutet MJ, Dumas M, Desproges-Gotteron R. Tick bite meningoradiculoneuritis. Neurology 1987;37:749-753.
41. Logigian EL, Steere AC. Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease. Neurology 1992; 42:303.
42. Halperin JJ, Pass HL, Anand AK, Luft BJ, Volkman DJ, Dattwyler RJ. Nervous system abnormalities in Lyme disease. Ann N Y Acad Sci 1988;539:24-34.
43. Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology 1990;40: 1340-1343.
44. Krupp LB, Masur D, Schwartz J, et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol 1991;48:1125-1129.
45. Kaplan RF, Meadows ME, Vincent LC, Logigian EL, Steere AC. Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and non-psychotically depressed patients. Neurology 1992;42:1263-1267.
46. Halperin JJ, Heyes MP. Neuroactive kynurenines in Lyme borreliosis. Neurology 1992;42:43-50.
47. Garcia Monco JC, Fernandez-Villar B, Benach JL. Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J Infect Dis 1989;160:497-506.
48. Garcia Monco JC, Villar BF, Szczepanski A, Benach JL. Cytotoxicity of Borrelia burgdorferi for cultured rat glial cells. J Infect Dis 1991;163:1362-1366.
49. Schmutzhard E, Pohl P, Stanek P. Borrelia burgdorferi antibodies in patients with relapsing-remitting form and chronic progressive form of multiple sclerosis. J Neurol Neurosurg Psychiatry 1988;51:1215-1218.
50. Coyle PK. Borrelia burgdorferi antibodies in multiple sclerosis patients. Neurology 1989;39:760-761.
51. Panitch HS, Hirsch RL, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987;37:1097-1102.
52. Waisbren B, Cashman N, Schell R, Johnson R. Borrelia burgdorferi antibodies and amyotrophic lateral sclerosis. Lancet 1987;2:332-333.
53. Fredrikson S, Link H. CNS-borreliosis selectively affecting central motor neurons. Acta Neurol Scand 1988;78:181-184.
54. Mandell H, Steere A, Reinhardt B, Yoshinari N, Munsat T. Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis. N Engl J Med 1989;320:255-256.
55. Halperin JJ, Kaplan GP, Brazinsky S, et al. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch Neurol 1990;47:586-594.
56. Pappolla MA, Omar R, Saran B, et al. Concurrent neuroborreliosis and Alzheimer's disease: analysis of the evidence. Hum Pathol 1989;20:753-757.
57. MacDonald AB, Miranda JM. Concurrent neocortical borreliosis and Alzheimer's disease. Hum Pathol 1987;18:759-761.
58. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme disease. Lancet 1988;1191-1193.
59. Pfister HW, Preac MV, Wilske B, Einhaupl KM. Cefotaxime vs. penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch Neurol 1989;46:1190-1194.
60. Preac Mursic V, Weber K, Pfister HW, et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 1989;17:355-359.
61. Baranton G, Perolat P, Dufresne Y, Postic D, Quentin R, Fouquet B. Isolation of Borrelia burgdorferi in the cerebrospinal fluid in a patient treated with penicillin [letter]. Presse Med 1989;18:637.
62. Pfister HW, Preac Mursic V, Wilske B, Schielke E, Sorgel F, Einhaupl KM. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis 1991;163:311-318.
63. Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994;44:1203-1207.
64. Appropriateness of parenteral antibiotic treatment for patients with presumed Lyme disease. A joint statement of the American College of Rheumatology and the Council of the Infectious Diseases Society of America [comment]. Ann Intern Med 1993;119.
65. Clark JR, Carlson RD, Sasaki CT, Pachner AR, Steere AC. Facial paralysis in Lyme disease. Laryngoscope 1985;95: 1341-1345.
66. Henriksson A, Link H, Cruz M, Stiernstedt G. Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome). Ann Neurol 1986;20:337-345.